- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07692763
Evaluating the YATAC Programme (YATAC)
The Young Adult Taking Action Program: Protocol for a Pilot Randomized Controlled Trial of Cancer Rehabilitation for Young Adults
Young adults aged 18-39 years with cancer often experience physical, psychological, and social challenges that affect their participation in everyday life and their health-related quality of life. Existing cancer rehabilitation services are rarely tailored to the specific needs of this age group. The Young Adults Taking Action (YATAC) programme was developed together with young adults with cancer, healthcare professionals, and researchers to provide age-specific rehabilitation that supports young adults in managing cancer-related challenges and returning to everyday life.
The aim of this pilot randomized controlled trial is to evaluate the feasibility of conducting a larger trial of the YATAC programme in a municipal rehabilitation setting. The study will examine recruitment, retention, acceptability of randomization, data completeness, assessment burden, and adverse events. In addition, the study will provide preliminary estimates of the programme's effects on health-related quality of life and self-efficacy.
Fifty young adults aged 18-39 years who are undergoing or have completed curative-intent treatment will be recruited through municipal cancer rehabilitation services in Aarhus Municipality, Denmark. Participants will be randomly assigned to receive either the 16-week YATAC programme or usual cancer rehabilitation services. The YATAC programme includes an individual needs assessment and goal setting, followed by group-based and individual sessions addressing physical activity, fatigue, sleep and cognitive challenges, mental health, sexuality and relationships, family and friends, nutrition, and education or work. Outcomes will be assessed at baseline and at 4, 6, and 12 months after enrolment.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Maria Aagesen, PhD
- Telefonnummer: 004529723294
- E-post: maagesen@health.sdu.dk
Studera Kontakt Backup
- Namn: Marc Sampedro Pilegaard, PhD
- Telefonnummer: 004520722972
- E-post: masamp@rm.dk
Studieorter
-
-
-
Aarhus, Danmark, 8000
- Rekrytering
- Folkesundhed (Public Health), the Municipality of Aarhus
-
Kontakt:
- Tenna Askjær, Physioterapist and MSc
- Telefonnummer: 004541859049
- E-post: tea@aarhus.dk
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Between 18 and 39 years of age
- Are currently undergoing or have completed curative-intent cancer treatment within the past five years
- Can understand and communicate in Danish and provide informed consent independently
- Have been referred to municipal cancer rehabilitation services in the Municipality of Aarhus
Exclusion Criteria:
- Diagnosed with cancer before the age of 18
- Previously or currently receive rehabilitation
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Standard rehabilitation
|
Participants assigned to the control group will receive the standard cancer rehabilitation programme offered through Folkesundhed Aarhus.
This includes physical exercise.
|
|
Experimentell: YATAC programme
|
The YATAC 2.0 intervention will consist of a 16-week multidimensional rehabilitation programme including a mandatory needs assessment and goal-setting component, which will determine the primarily group-based components in which the young adults will participate. These components will include: 1) Physical activity, 2) Fatigue, sleep, and cognitive challenges, 3) Mental health, 4) Sexuality and relationships, 5) Family and friends, 6) Nutrition, and 7) Education and work. Each participant will be assigned a designated contact person, either a nurse or physiotherapist, who will follow the young adult throughout the programme. The contact person will conduct the needs assessments and goal-setting consultations and contribute to selected group sessions. In addition, one of the contact persons will be present during group-based sessions alongside the primary facilitator to promote continuity, coordination, and a sense of safety throughout the rehabilitation trajectory. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Recruitment rate
Tidsram: Baseline
|
1) Recruitment rate: Number of participants included within the planned recruitment period (July 2026-June 2027).
Data will be collected using screening and recruitment logs completed by a responsible contact professional from the Municipality of Aarhus.
|
Baseline
|
|
Acceptability of randomisation
Tidsram: Baseline
|
2) Acceptability of randomisation: Proportion of randomised participants who accept allocation and commence their assigned study arm.
A contact professional from the Municipality of Aarhus will complete data recruitment and allocation records.
|
Baseline
|
|
Attrition rate
Tidsram: Up to 12 months after baseline
|
3) Attrition rate: Proportion of participants who withdraw during the intervention period.
Data about attrition will be collected using withdrawal registrations and participant records.
|
Up to 12 months after baseline
|
|
Adverse events
Tidsram: Four months after baseline
|
4) Adverse events: Frequency, type, and severity of intervention-related adverse events.
and serious adverse events.
Participants will be asked to self-report intervention-related adverse events and serious adverse events.
|
Four months after baseline
|
|
Completeness of data
Tidsram: Four months after baseline
|
5) Completeness of data collection: Completion of primary patient-reported outcome at primary endpoint.
Questionnaire completion logs will be used.
|
Four months after baseline
|
|
Assessment burden
Tidsram: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
6) Assessment burden: Participant-reported burden and acceptability of assessments.
Short evaluation survey completed after assessments using 5-point Likert.
|
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Health-related quality of life
Tidsram: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Improvements of the YATAC programme will be evaluated using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). EORTC QLQ-C30 is a cancer-specific and internationally validated instrument consisting of 30 items across 15 domains, including five functional scales, three symptom scales, six single symptom items, and a global health status/quality of life scale. Scores are linearly transformed to a 0-100 scale according to the EORTC scoring manual. Higher scores on functional and global health status scales indicate better functioning and HRQoL, whereas higher symptom scores indicate greater symptom burden. The primary endpoint of the intervention will be global health status/quality of life four months after baseline. The remaining outcomes from the EORTC QLQ-C30 include: physical, role, emotional, cognitive, and social functioning; fatigue; pain; dyspnoea; and insomnia. |
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
|
AYA-specific quality of life
Tidsram: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Improvements of the YATAC programme will also be evaluated using the AYA-specific quality of life questionnaire, which is a supplementary module in the EORTC QLQ-AYA30 developed for adolescents and young adults with cancer aged 14-39 years. The questionnaire includes five multi-item scales assessing: 1) Activity limitations, 2) Worry about cancer and the future, 3) Self-esteem, 4) Relationships, and 5) Positive changes. In addition, nine single items address domains such as work/education, romantic and sexual life, relocation, caregiving responsibilities, and diet restrictions. Scores are transformed to a 0-100 scale, where higher scores reflect greater symptom burden, except for positive changes, where higher scores indicate better functioning The outcomes from EORTC QLQ-A include: Activity limitations, worry about cancer and the future, self-esteem, relationships, positive changes, and work/education, romantic and sexual life, relocation. |
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
|
Self-Efficacy
Tidsram: * Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Improvements of the YATAC programme will also be evaluated using the Self-Efficacy for Managing Chronic Disease 6-item Scale (SES6G) consisting of six items rated on a 10-point Likert scale ranging from 1 ("not at all confident") to 10 ("totally confident").
The mean score across items represents the overall self-efficacy score, with higher scores indicating greater confidence in managing health-related challenges.
|
* Baseline * Four months after baseline * Six months after baseline * 12 months after baseline
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Embedded qualitative study
Tidsram: Up to four months baseline
|
An embedded qualitative study will be conducted alongside the pilot RCT to explore barriers and facilitators related to recruitment, participation, retention, and acceptability of participation in rehabilitation intervention trials among young adults with cancer.
|
Up to four months baseline
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Marc Sampedro Pilegaard, PhD, Social Medicine and Rehabilitation, Gødstrup Hospital
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Young Adult Taking ACtion
- R379-A22563 (Annat bidrag/finansieringsnummer: Danish Cancer Society)
- 23-20-0478 (Annat bidrag/finansieringsnummer: The Aase and Ejnar Danielsen Foundation)
- R95-A4572 (Annat bidrag/finansieringsnummer: The Central Region of Denmark)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Tidsram för IPD-delning
Kriterier för IPD Sharing Access
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .